Cardiotoxicity of checkpoint inhibitors: focus on immune side effects
Objective: The use of checkpoint inhibitors in cancer will continue to expand in the coming years, which is a promising area for future clinical research. However, diagnosis of immune-related side effects is challenging due to its heterogeneous clinical manifestations, which range from subclinical t...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Center for Scientific Research and Development of Education.
2024-04-01
|
| Series: | Heart Vessels and Transplantation |
| Subjects: | |
| Online Access: | https://hvt-journal.com/articles/art480 |